Literature DB >> 2765297

Biologic and molecular characterization of producer and nonproducer clones from HUT-78 cells infected with a patient HIV isolate.

M Federico1, F Titti, S Buttó, A Orecchia, F Carlini, B Taddeo, B Macchi, N Maggiano, P Verani, G B Rossi.   

Abstract

HUT-78 cells were infected with a reverse transcriptase (RT)-positive supernatant of a culture of peripheral blood lymphocytes (PBL) from an AIDS patient and then cloned. Of these clones, two have been isolated and characterized. Clone D10 is persistently and productively infected with an HIV variant. The clone F12, in spite of the presence of an integrated full-length HIV provirus, does not release virus particles in the medium. D10 and F12 clones substantially differ in terms of protein pattern; that is, D10 is super-imposable to infected HUT-78 cells, whereas F12 exhibits a decreased uncleaved p55 gag precursor and the presence of uncleaved gp160 and of a unique p19, although they do not show qualitative or quantitative differences in viral RNA synthesis. Restriction patterns of F12 proviral DNA do not show major genomic deletions. These results indicate that F12 clone cells carry an HIV genome with minor mutations that probably affect the correct production of viral proteins at a posttranscriptional level. In addition, the F12 clone is resistant to high-multiplicity superinfection with HIV-1 or HIV-2.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2765297     DOI: 10.1089/aid.1989.5.385

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  8 in total

1.  gag, vif, and nef genes contribute to the homologous viral interference induced by a nonproducer human immunodeficiency virus type 1 (HIV-1) variant: identification of novel HIV-1-inhibiting viral protein mutants.

Authors:  P D'Aloja; E Olivetta; R Bona; F Nappi; D Pedacchia; K Pugliese; G Ferrari; P Verani; M Federico
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

2.  Analysis of long-term viral expression in CEM cells persistently infected with non syncytium-inducing HIV-1 strains.

Authors:  J Yelle; R Morisset; L Thibodeau
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

3.  A nonproducer, interfering human immunodeficiency virus (HIV) type 1 provirus can be transduced through a murine leukemia virus-based retroviral vector: recovery of an anti-HIV mouse/human pseudotype retrovirus.

Authors:  M Federico; F Nappi; G Ferrari; C Chelucci; F Mavilio; P Verani
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

4.  Productive expression state confers resistance of human immunodeficiency virus (HIV)-2-infected lymphoma cells against superinfection by HIV-1.

Authors:  G K von Dalnok; A Kleinschmidt; M Neumann; C Leib-Moesch; V Erfle; R Brack-Werner
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

5.  Macrophages transmit human immunodeficiency virus type 1 products to CD4-negative cells: involvement of matrix metalloproteinase 9.

Authors:  Claudia Muratori; Antonella Sistigu; Eliana Ruggiero; Mario Falchi; Ilaria Bacigalupo; Clelia Palladino; Elena Toschi; Maurizio Federico
Journal:  J Virol       Date:  2007-06-20       Impact factor: 5.103

6.  Cell activation and HIV-1 replication in unstimulated CD4+ T lymphocytes ingesting exosomes from cells expressing defective HIV-1.

Authors:  Claudia Arenaccio; Chiara Chiozzini; Sandra Columba-Cabezas; Francesco Manfredi; Maurizio Federico
Journal:  Retrovirology       Date:  2014-06-12       Impact factor: 4.602

7.  The C-Terminal Domain of Nefmut Is Dispensable for the CD8+ T Cell Immunogenicity of In Vivo Engineered Extracellular Vesicles.

Authors:  Chiara Chiozzini; Francesco Manfredi; Flavia Ferrantelli; Patrizia Leone; Andrea Giovannelli; Eleonora Olivetta; Maurizio Federico
Journal:  Vaccines (Basel)       Date:  2021-04-12

8.  Latent HIV-1 is activated by exosomes from cells infected with either replication-competent or defective HIV-1.

Authors:  Claudia Arenaccio; Simona Anticoli; Francesco Manfredi; Chiara Chiozzini; Eleonora Olivetta; Maurizio Federico
Journal:  Retrovirology       Date:  2015-10-26       Impact factor: 4.602

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.